Drug Use Study With VYVANSE® in Australia for Binge Eating Disorder

Status Completed

Clinical Trial Summary

This study will check how and to whom Vyvanse is prescribed in Australia by retrospectively analyzing a prescription database with additional information provided by a physician survey.

Clinical Trial Description

This is a drug utilization study (DUS) using cross-sectional database analysis of participants who are prescribed lisdexamfetamine dimesylate for treatment of BED. The study will combine data from two sources of patient-level drug utilization data for lisdexamfetamine dimesylate: - NostraData database: Longitudinal participant level prescription dispensing database - Physician survey: De-identified participant data provided by representative psychiatrists and other physicians expected to treat participants with BED in Australia. In the NostraData database, actual drug dispensing data are collected, which allows for the generation of information on actual drug usage. However, these data do not contain certain participant variables, such as age and indication, needed to monitor potential off-label use. Therefore, these data must be supplemented with another data source. The physician survey will provide the data not included in the NostraData database. The DUS will enroll approximately 150 participants. This DUS will be conducted in Australia. The overall time for data collection in the study will be approximately 36 months after the launch date of lisdexamfetamine dimesylate. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04866043
Study type	Observational
Source	Takeda
Contact
Status	Completed
Phase
Start date	June 1, 2019
Completion date	October 15, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04572087` - Ameliorating Cognitive Control in Binge Eating Disorder	N/A
Completed	`NCT03063606` - Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Specialist Treatment	Phase 2/Phase 3
Completed	`NCT03678766` - CHARGE: Controlling Hunger and ReGulating Eating	N/A
Enrolling by invitation	`NCT04174703` - Preparing for Eating Disorders Treatment Through Compassionate Letter-Writing	N/A
Terminated	`NCT03279731` - Binge Eating Liraglutide Intervention	Phase 3
Terminated	`NCT04278755` - Binge Eating & Birth Control	Phase 2
Completed	`NCT02419326` - Uniting Couples In the Treatment of Eating Disorders (UNITE)	N/A
Completed	`NCT00210808` - A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With Obesity	Phase 2/Phase 3
Recruiting	`NCT05937243` - Identifying Effective Technological-based Augmentations to Enhance Outcomes From Self-help Cognitive Behavior Therapy for Binge Eating	N/A
Completed	`NCT04115852` - Interoceptive Nutritional Processing in Healthy Participants and Patients With Binge-Eating-Disorder
Completed	`NCT03113669` - Project BITE: Binge Intervention Target Effectiveness	N/A
Completed	`NCT04265131` - Emotion Regulation in Eating Disorders: How Can Art Therapy Contribute to Treatment Outcome?	N/A
Recruiting	`NCT06431854` - Evaluation of a New Treatment Program for Adolescents With Eating Disorders: MINERVA Program	N/A
Completed	`NCT06230107` - The Effects of Nutritional Intervention in Participants With Eating Disorders.	N/A
Completed	`NCT03712748` - Online Imaginal Exposure	N/A
Recruiting	`NCT04076553` - Augmenting Cognitive Behavioral Therapy With Inhibitory Control Training	N/A
Not yet recruiting	`NCT04101032` - eBEfree - an ICT Adaptation of BEfree	N/A
Terminated	`NCT05911334` - Feasibility of the ROADE Program	N/A
Completed	`NCT03317379` - Evaluation of the Communities of Healing Mentorship/Support Group Program: Assessment of Preliminary Efficacy	N/A
Completed	`NCT02783872` - Emotion Regulation and Binge Eating in Youth With Obesity